Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Plos One|August 20, 2011
The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trialsChristina V Warner, Stephanie B Syc, Aleksandra M Stankiewicz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2025
MRI characteristics during attack and remission distinguish patients with MOG antibody-associated disease from multiple sclerosisStephanie B Syc-Mazurek, Laura Cacciaguerra, Deena A Tajfirouz, et al.
Neurology|May 6, 2024
Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated DiseaseLaura Cacciaguerra, Omar Abdel-Mannan, Dimitrios Champsas, et al.
Neurology|September 29, 2022
Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody-Associated DiseaseStephanie B Syc-Mazurek, John J Chen, Pearse Morris, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 1, 2026
TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test ResultsAndreu Vilaseca, Angeliki G Filippatou, Yana Said, et al.
Brain : a Journal of Neurology|January 22, 2011
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomographyShiv Saidha, Stephanie B Syc, Mohamed A Ibrahim, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 9, 2026
Psychiatric comorbidities cluster early after onset in MOGAD: a cross-sectional comparative study with MS and NMOSDMoritz Niederschweiberer, Cicek Bakir, Nisa Vorasoot, et al.
Annals of Clinical and Translational Neurology|March 9, 2019
Retinal measurements predict 10-year disability in multiple sclerosisAlissa Rothman, Olwen C Murphy, Kathryn C Fitzgerald, et al.
Pageof 4